Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2689–2712 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Tennis Elbow, Lateral Epicondylitis \(Tennis Elbow\), Lateral Elbow Tendinopathy
Interventions: CTM, Celestone; Device · Drug
Lead sponsor: Indiana Hand to Shoulder Center; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Ulcerative Colitis, Colitis, Ulcerative
Interventions: VE202, Vancomycin Oral Capsule, VE202 Placebo, Vancomycin Placebo; Biological · Drug · Other
Lead sponsor: Vedanta Biosciences, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: Naples, Florida • Orlando, Florida • Decatur, Georgia + 6 more

Conditions: Arthroplasty Complications
Interventions: Pharmacogenomics Testing; Diagnostic Test
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Postbariatric Hypoglycemia
Interventions: exendin 9-39, Placebo; Drug · Other
Lead sponsor: Eiger BioPharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 5
States / cities: Palo Alto, California • Aurora, Colorado • Baltimore, Maryland + 2 more

Conditions: Irritable Bowel Syndrome
Interventions: cognitive-behavioral; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 70 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Menopause Surgical, Estrogen Deficiency, Adiposity, Follicle-Stimulating Hormone Deficiency, Hormone Deficiency
Interventions: 'Surgical Menopause' Group, 'Drug-Induced Menopause' Group; Procedure · Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Dementia
Interventions: DSM-H Hospice Edition performance improvement program, Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Dry Eye Syndromes, Corneal Disease
Interventions: In vivo confocal microscopy (IVCM); Other
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 438 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts • Philadelphia, Pennsylvania

Conditions: HIV Associated Diarrhea
Interventions: Crofelemer 125 mg, Crofelemer 250 mg, Crofelemer 500 mg, Placebo; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 79
States / cities: Huntsville, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 53 more

Conditions: Post Operative Pain
Interventions: Maxigesic IV, IV Acetaminophen, IV Ibuprofen, Placebo IV; Drug
Lead sponsor: AFT Pharmaceuticals, Ltd.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Pasadena, Maryland • Austin, Texas

Conditions: Healthy
Interventions: JNJ-39439335 10 mg, JNJ-39439335 25 mg, JNJ-39439335 50 mg, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 20 Years to 55 Years · Male only
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Cypress, California

Conditions: Postoperative Pain
Interventions: Bupivacaine HCl, SKY0402; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 6
States / cities: Birmingham, Alabama • Davis, California • Laguna Hills, California + 3 more

Conditions: Lateral Canthal Lines
Interventions: RT001, Placebo; Drug · Other
Lead sponsor: Revance Therapeutics, Inc.; Industry
Eligibility: 30 Years to 60 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 9
States / cities: Birmingham, Alabama • San Francisco, California • Coral Gables, Florida + 5 more

Conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Lymphoma Cancer, Gynecological Cancers
Interventions: group intervention and questionnaires, individual phone intervention and questionnaires, expressive writing (arm will not be include in the randomization); Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 70 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2025
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Sedative During Endoscopy
Interventions: Pico 4 Enterprise headset with noise cancelling headphones; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Dental Caries
Interventions: Radiographic contrast agent. Sodium Iodide.; Device
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 99 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Pregnancy
Interventions: 600 mg DHA, 300 mg DHA, Placebo; Dietary Supplement
Lead sponsor: Colorado State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 871 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2014
U.S. locations: 2
States / cities: Denver, Colorado • Fort Collins, Colorado

Conditions: Hearing Loss
Interventions: Spanish-Language Hearing Loss Toolkit for Self-Management, American Speech-Language-Hearing Association (ASHA) Audiology Series Spanish Language Handouts; Other
Lead sponsor: University of South Florida; Other
Eligibility: 50 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Breast Carcinoma
Interventions: Counseling, Written materials; Behavioral
Lead sponsor: American Scitech International; Other
Eligibility: 25 Years to 85 Years · Female only
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Englishtown, New Jersey

Conditions: Colo-rectal Cancer, Anesthesia
Interventions: IV Medications, placebo; Drug · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Iron Deficiency Anemia, Pregnancy
Interventions: Ferric derisomaltose, Ferrous sulfate; Drug
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 8
States / cities: Birmingham, Alabama • Miami, Florida • Ann Arbor, Michigan + 4 more

Conditions: Cardiovascular Diseases
Interventions: PATH Intervention, Attention Control Intervention, Physical activity tracker, Dietary education; Behavioral · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetic Kidney Disease
Interventions: Finerenone (BAY94-8862), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 7,352 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 173
States / cities: Birmingham, Alabama • Fort Payne, Alabama • Huntsville, Alabama + 124 more

Conditions: Femur Fracture
Interventions: Femoral venting+ intramedullary nailing, Standard intramedullary nailing; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Efficacy of CTM for Tennis ELbow

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

Pharmacogenetics for Pain Management in Joint Replacement Patients

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

Nursing Management of Irritable Bowel Syndrome:Improving Outcomes

Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause

The Dementia Symptom Management at Home Program Hospice Edition

Prospective Study to Validate the Imaging Biomarker for NCP (R33)

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

Maxigesic IV Phase 3 Bunionectomy Study

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants

Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

Implementing Virtual Reality (VR) to Reduce Sedation

Use of Radiographic Contrast to Detect Dental Caries

DHA Supplementation and Pregnancy Outcome

Development and Assessment of a Spanish-Language Hearing Loss Toolkit for Self-Management

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?

Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

Web-based Physical Activity Intervention to Promote Physical Activity

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Effect of a Femoral Venting Hole on Embolic Load in Prophylactic Intramedullary Nailing